DMHC orders Astiva Health to stop adding enrollees over tangible net equity shortfalls
Published November 15, 2026 · Coverage November 8–14, 2026, Pacific · Medium priority
On November 9, 2026, the California Department of Managed Health Care (DMHC) issued an Order to Cease and Desist in enforcement matter 26-069 against Astiva Health, Inc., a health plan it licenses. The order directs Astiva to cease accepting the assignment or addition of enrollees without the Director's prior written approval, and it took effect immediately. It does not apply to dependents of current enrollees or to enrollees who chose the plan during an open enrollment or other selection period before the prohibition took effect. Astiva must file a Verified Statement affirming compliance by December 9, 2026. Separately, paragraph 21 of the order says Astiva shall file documentation with DMHC no later than 60 calendar days from the date of the order that clearly sets forth how Astiva is operating in compliance with the order.

Background
DMHC enforces the Knox-Keene Health Care Service Plan Act of 1975, which requires health plans to maintain a minimum amount of tangible net equity (TNE) at all times. According to the order, Astiva's Financial Reporting Forms showed TNE below the minimum for ten reporting periods ending between December 31, 2024 and August 31, 2026, and Astiva has not kept TNE at 150 percent of the minimum as a June 15, 2023 Undertakings Agreement with DMHC requires. DMHC wrote to Astiva on May 15, 2026 about the deficiencies, and the order says the Centers for Medicare & Medicaid Services (CMS) confirmed that other plans are available to enrollees in the region.
Who this affects
Hospitals, medical groups and other providers that contract with Astiva Health, Inc., and their revenue-cycle and managed-care contracting teams.
Why it matters
A plan that DMHC finds has been below its minimum tangible net equity in ten reporting periods since December 2024, and below the 150 percent level its agreement with DMHC requires since the quarter ending December 31, 2024, is a payment risk for the hospitals and medical groups that contract with it: claims and capitation owed by a financially weak plan may be paid late or not in full. The freeze on new enrollment limits the plan's membership growth while it remains in effect, apart from dependents of current enrollees and enrollees who chose the plan before the freeze. This is an inference from the order's findings; the order does not address provider payments.
Required actions
- None stated for hospitals or other providers that contract with Astiva. The order's requirements apply to Astiva: it must cease accepting the assignment or addition of enrollees without the Director's prior written approval, file documentation within 60 calendar days of the order, and file the Verified Statement by December 9, 2026, as described above.
Recommended action
- Identify any contracts, letters of agreement or delegated arrangements with Astiva Health, Inc., and review current receivables and payment timeliness under them.
- Have managed-care contracting and finance check DMHC's enforcement search for any further order or document in matter 26-069 after the December 9, 2026 Verified Statement date.
Implementation playbook
- Identify contracts, letters of agreement and delegated arrangements with Astiva Health, Inc., and pull current receivables and payment timeliness under them. Owner: Managed Care Contracting and Finance. Due: 2026-11-30.
- Check DMHC's enforcement search for any further order or document in matter 26-069. Owner: Managed Care Contracting. Due: 2026-12-16, a week after the December 9, 2026 Verified Statement date.
Scope and timing
- Authority status
- Disposition
- Responsible owner
- Managed Care Contracting; Revenue Cycle; Finance
- Effective date
- 2026-11-09
- Compliance date
- 2026-12-09
- Other dates
- Order dated November 9, 2026. Hearing may be requested within 30 days from the date of service of the order
Not established
Whether Astiva requested a hearing was not established. The order does not say which products or lines of business Astiva offers.
Sources
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Enforcement Briefing report →